124 related articles for article (PubMed ID: 10737716)
1. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis.
Fujimoto J; Yasui W; Tahara H; Tahara E; Kudo Y; Yokozaki H; Tahara E
Cancer Lett; 2000 Feb; 149(1-2):125-34. PubMed ID: 10737716
[TBL] [Abstract][Full Text] [Related]
2. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
4. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
5. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
7. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
Yasui W; Yokozaki H; Fujimoto J; Naka K; Kuniyasu H; Tahara E
J Gastroenterol; 2000; 35 Suppl 12():111-5. PubMed ID: 10779229
[TBL] [Abstract][Full Text] [Related]
10. Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa.
Machado JC; Carneiro F; Blin N; Sobrinho-Simões M
Eur J Cancer Prev; 1996 Jun; 5(3):169-79. PubMed ID: 8818606
[TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma.
Feng G; Zhang Y; Yuan H; Bai R; Zheng J; Zhang J; Song M
Mol Med Rep; 2014 Jan; 9(1):109-17. PubMed ID: 24190027
[TBL] [Abstract][Full Text] [Related]
13. Expression of the pS2 gene in normal, benign and neoplastic human stomach.
Luqmani Y; Bennett C; Paterson I; Corbishley CM; Rio MC; Chambon P; Ryall G
Int J Cancer; 1989 Nov; 44(5):806-12. PubMed ID: 2583860
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.
To KF; Leung WK; Lee TL; Yu J; Tong JH; Chan MW; Ng EK; Chung SC; Sung JJ
Int J Cancer; 2002 Dec; 102(6):623-8. PubMed ID: 12448005
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma.
Oue N; Shigeishi H; Kuniyasu H; Yokozaki H; Kuraoka K; Ito R; Yasui W
Int J Cancer; 2001 Sep; 93(6):805-9. PubMed ID: 11519041
[TBL] [Abstract][Full Text] [Related]
17. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.
Carvalho R; Kayademir T; Soares P; Canedo P; Sousa S; Oliveira C; Leistenschneider P; Seruca R; Gött P; Blin N; Carneiro F; Machado JC
Lab Invest; 2002 Oct; 82(10):1319-26. PubMed ID: 12379766
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
